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Background: Alleles Prnpa and Prnpb of mouse prion protein (PrP) influence the incubation period of prion disease.
Results: PrPa and PrPb, products of these alleles, aggregate differently in vitro.
Conclusion: The polymorphism at 108/189 influences the oligomeric stages of PrP polymerization.
Significance: Elucidating the mechanism of PrP aggregation is relevant to understanding prion disease susceptibility, prion
strains, and species barriers.
Prion diseases are fatal neurodegenerative disorders associ-
ated with the polymerization of the cellular form of prion pro-
tein (PrPC) into an amyloidogenic -sheet infectious form
(PrPSc). The sequence of host PrP is the major determinant of
host prion disease susceptibility. Inmice, the presence of allele a
(Prnpa, encoding the polymorphism Leu-108/Thr-189) or b
(Prnpb, Phe-108/Val-189) is associated with short or long incu-
bation times, respectively, following infection with PrPSc. The
molecular bases linking PrP sequence, infection susceptibility,
and convertibility of PrPC into PrPSc remain unclear. Here we
show that recombinant PrPa and PrPb aggregate and respond to
seeding differently in vitro. Our kinetic studies reveal differ-
ences during the nucleation phase of the aggregation process,
where PrPb exhibits a longer lag phase that cannot be com-
pletely eliminated by seeding the reaction with preformed
fibrils. Additionally, PrPb ismore prone to propagate features of
the seeds, as demonstrated by conformational stability and elec-
tron microscopy studies of the formed fibrils. We propose a
model of polymerization to explain how the polymorphisms at
positions 108 and 189 produce the phenotypes seen in vivo. This
model also provides insight into phenomena such as species bar-
rier and prion strain generation, two phenomena also influ-
enced by the primary structure of PrP.
Prion diseases are protein folding disorders that include
Creutzfeldt-Jakob disease in humans, bovine spongiform
encephalopathy in cattle, chronic wasting disease in cervids,
and scrapie in sheep. These diseases have several similarities to
other protein folding neurodegenerative disorders, such as
Alzheimer disease, but the hallmark of prion diseases is the
infectious nature of the protein responsible for the neurode-
generation (1). The protein in question is the prion protein
(PrP),2 and its infectious form is generated when the mono-
meric, predominantly -helical, and soluble form (PrPC) is
structurally converted into an amyloid structure, oligomeric in
nature, high in  sheet, and partially protease-resistant (PrPSc).
Many different forms of PrPSc can be generated, and this struc-
tural promiscuity is thought to be the molecular basis for prion
“strains,” defined by distinct incubation time, phenotype,
and/or pathology (2–4). Although certain structures of PrPSc
may be better able to convert PrPC from select species, once the
process has begun, it is relentless. More PrPC is converted into
PrPSc, PrPSc accumulates, and neuronal death follows.
The primary structure of the host PrPC is a major determi-
nant of the host prion disease susceptibility. For example, subtle
differences in PrPC sequence are sufficient to render some
mammals, such as rabbits and horses, immune to prion disease
(5–7). Sometimes this species barrier can be crossed, although
generally it is an inefficient process, with newly infected species
having prolonged incubation periods (7–9). Interestingly, with
sequential passages through the new host species, incubation
periods become shorter and stabilize at a new and constant
incubation period for that host (9). During these passages, it is
believed that a process of conformational adaptation or a selec-
tion of one subtype of PrPSc conformation is taking place (10).
This adaptation is influenced primarily by the sequence of host
PrP (7).
The PrP sequence can also vary within a species; these poly-
morphisms too can influence disease susceptibility or even phe-
notype. In humans, methionine homozygosity at codon 129 of
the prion protein gene (Prnp) increases susceptibility to prion
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disease. Codon 129 also determines the phenotype of a genetic
form of Creutzfeldt-Jakob disease caused by the D178N muta-
tion (11). The effect of Prnp polymorphism on disease suscep-
tibility can be found in other species too, including codon 132 in
cervids (12) and codons 136/154/171 in sheep (13–17).
Given the clear influence of PrPC sequence on prion disease,
the next question is by what mechanism is this influence con-
ferred? The PrPC sequence may dictate which PrPSc conforma-
tions are permissive or preferred, or it may influence how read-
ily the conversion process can occur under the guidance a given
PrPSc structure. Although the mechanism of prion conversion
into amyloids remains obscure, the canonical model proposed
for amyloid formation is nucleated polymerization (18) consist-
ing of two phases: (i) a nucleation phase where monomers
undergo conformational change and self-associate to formolig-
omeric nuclei; and (ii) an elongation phase, in which nuclei
rapidly grow by the further addition of monomers, forming
larger fibrils until saturation (19). PrPC sequence may regulate
either or both of these phases.
In mice, the presence of Prnp allele a (Prnpa, Leu-108/Thr-
189) or allele b (Prnpb, Phe-108/Val-189) dramatically influ-
ences the incubation period of prion infection (20, 21). Typi-
cally, Prnpa mice exhibit shorter incubation times (100–200
days) when compared with Prnpb mice (255–300 days) (22–
24), although the opposite trendwas seen in one study (21). The
reason for this discrepancy is not clear, but different prion
strains were used; in the latter study, the strain used for inocu-
lation was first passaged in Prnpb mice, whereas Prnpa mice
were used as the source of strains for the other studies (25, 26).
As the differences in the primary structure of PrPa and PrPb
are the main distinguishing features in these studies, it follows
that this polymorphism is the major factor determining the
incubation period in vivo. Both residues have been implicated
in prion disease, either by playing a role in the initial stages of
PrPC conversion (27–29) or by influencing the susceptibility to
prion infection (13–16).
We hypothesized that different polymerization kinetics
could explain the different incubation periods of these two
alleles and that we would be able to detect these kinetic differ-
ences in vitro by putting recombinant mouse PrPa or PrPb into
fibril-forming assays. Having found this to be the case, we then
proceeded to use this in vitro model of conversion to explore
the potential mechanisms of fibril formation process in each
allele type.
In this work, we compare for the first time the kinetics of
amyloid fibril formation of recombinant mouse PrPa and PrPb.
From these results, togetherwith the conformational and struc-
tural analysis of the formed fibrils, we propose different mech-
anisms of polymerization for these two isoforms of mouse PrP.
EXPERIMENTAL PROCEDURES
Expression and Purification of Mouse PrP (89–230)—The
codon-optimized synthetic genes corresponding to the C-ter-
minal domain of mouse prion protein (89–230) for allele A and
B were expressed in Escherichia coli BL21 (DE3) as described
earlier (30). The E. coli BL21 (DE3) cells were grown in 25ml of
LB plus 100 g/ml ampicillin overnight. 10 ml was used to
inoculate 500 ml of LB plus 100 g/ml ampicillin and set to
shake at 225 rpm at 37 °C until it reached an A600 of about 1.0.
Cells were pelleted down and resuspended in fresh Terrific
Broth plus 100g/ml ampicillinmediumand set to shake at 225
rpm at 37 °C for 1 h before induction with 1 mM isopropyl-1-
thio--D-galactopyranoside. Induced cells were grown for a
further 12–18 h to reach an A600 of about 2.0. These cells were
harvested by centrifugation at 4,500  g for 25 min at 4 °C. The
cell pellet was resuspended in 100ml of lysis buffer (8 M urea, 10
mM Tris, 100 mM Na2PO4, pH 8.0) using vortex and incubated
at room temperature for 1 h before sonication using a microtip
at 30% amplitude for 10 cycles of 30 s. The cell debris was
removed by centrifugation at 15,000  g for 1 h. The superna-
tant was incubated with 30 ml of nickel-nitrilotriacetic acid
resinwith continuous stirring for 30–45min and transferred to
a column. On-column refolding was done by slow gradual
change from8 to 0Murea (10mMTris, 100mMNa2PO4, pH6.3)
(31, 32). Contaminants were removed using 5 column volumes
of 10 mM Tris, 100 mM Na2PO4, 50 mM imidazole, pH 6.3. The
His-tagged prion proteins were eluted using 10 mM Tris, 100
mM Na2PO4, 500 mM imidazole, pH 6.5. The sample was dia-
lyzed against 10 mM Tris, 2 mM CaCl2, pH 6.3, and the His tag
was removed with thrombin by incubation for 24 h at 4 °C. The
samples were dialyzed against 10 mM ammonium carbonate,
lyophilized, and kept at 80 °C until use.
PrP Fibril Formation—Lyophilized samples of recombinant
PrPa and PrPbwere dissolved in 6M guanidiniumhydrochloride
(GdnHCl) at a protein concentration of 5 mg/ml. Stock solu-
tionswere diluted in 50mMsodiumphosphate buffer, pH7.0, to
reach a final concentration of 2 M GdnHCl. The final protein
concentration was 0.5 mg/ml unless otherwise indicated. Fibril
formation reactions were carried out in 96-well plates (white
plate, clear bottom, Costar 3610) covered with thermal adhe-
sive sealing film (08-408-240; Fisher Scientific) at reaction vol-
umes of 200 l/well. The samples were incubated at 37 °C with
continuous shaking at 500 rpm in the presence of 10 M ThT.
Fluorescence measurements were taken at 445/482 nm excita-
tion/emission and 475 nm cutoff on a M5 SpectraMax fluores-
cence plate reader (MolecularDevices). At least three replicates
were measured. For seeding experiments, the reaction was car-
ried out in the presence of sonicated preformed fibrils (1min in
a cup sonicator). Estimation of lag phase was done as reported
previously (33). In brief, the data were fitted to the limiting
forms of the hyperbolic cosine solution of the equation devel-
oped by Bishop and Ferrone (34). The data corresponding to
the nucleation stage were fitted to the quadratic equation
1⁄2B2At2, whereas those corresponding to the elongation stage
were fitted to the exponential function 1⁄2AeBt, where t is time
andA andB are fitting coefficients. The lag phasewas defined as
the time point where the fitting curves for quadratic and expo-
nential equation intersect. If the time value for the intersection
point is equal to or less than zero, there is an absence of lag
phase.
Prefibrillar Oligomer Formation—Tomonitor the formation
of ThT-negative oligomers, aggregation reactions were carried
out in 1.5-ml test tubes (protein LoBind, Eppendorf) at reaction
volumes of 1.2 ml. The samples were incubated at 37 °C with
continuous shaking at 500 rpm, and 50 l of sample was with-
drawn at different times and incubated for 15 min at room
Prnp Allele Effects on Fibril Formation Kinetics and Seeding
























temperature with 1 l of 15 M p-FTAA or 1 l of 2 mM ThT.
Spectra for p-FTAA were recorded between 480 and 700 nm
with excitation at 450 nm. The ratio 530/630 nm was plotted.
Circular Dichroism—1ml of 0.5 mg/ml PrPa or PrPb was put
under aggregation conditions in a 1.5-ml test tube, and at indi-
cated time points, aliquots of 40 l were removed for CDmea-
surements in a 0.1-mmcuvette. The spectra were recorded on a
Chirascan CD spectrometer (Applied Photophysics) instru-
ment between 200 and 260 nm, with sampling points every 1
nm. For each sample, 10 scans were averaged, and base-line
spectra were subtracted. Thermal denaturation and renatur-
ation were monitored by heating the sample from 15 to 70 °C
and cooling from 70 to 15 °C at 1 °C/min in a 1-mm cuvette.
The ellipticity was recorded at 222 nm, and the percentage of
unfolded protein was plotted. For GdnHCl-induced denatur-
ation, separate samples were prepared by diluting a concen-
trated stock of PrP to 0.5mg/ml in 50mM phosphate buffer, pH
7.0, and varying the GdnHCl concentration. The samples were
incubated for 2 h at room temperature, and spectra were
recorded in a 1-mm cuvette. Data were processed using
Applied Photophysics Chirascan Viewer and Microsoft Excel.
Conformational Stability Assay—Aliquots of 0.1 mg of PrPa
and PrPb fibrils were incubated with various concentrations of
GdnHCl for 2 h at 25 °C. The samples were diluted with con-
formational stability assay buffer (10 mM Tris-HCl, pH 8.0, 150
mM NaCl, 0.5% Nonidet P-40, and 0.5% deoxycholate) to reach
a final concentration of 0.4 M GdnHCl and digested with 10
g/ml proteinase K for 1 h at 37 °C. The reaction was stopped
with a 5-min incubation with 1.5 mM PMSF at 37 °C. Samples
were centrifuged 1 h at 100,000  g, and the pellet was resus-
pended in 20 l of sample buffer, boiled for 10 min, and loaded
onto NuPAGE 4–12% BisTris gels. Protein was transferred to
PVDF membrane and detected with SAF83 antibody.
Transmission Electron Microscopy (TEM)—Once the aggre-
gation reaction reached the plateau phase, aliquots of PrPa and
PrPb samples were adsorbed onto 400 mesh carbon-coated
copper grids (Ted Pella, Inc., Redding CA), negatively stained
with 2% (w/v) uranyl acetate, and subsequently imaged in a
Philips EM-420 transmission electron microscope (FEI Ltd.,
Eindhoven, The Netherlands) operated at 100 kV. Images were
recorded on films (Kodak SO-163) at a nominal magnification
of 13,500 to 31,000. The films were developed and then
scanned at 21.16 m/pixel for a final resolution range of 6.8–
15.7 Å/pixel. Fibril dimensions were determined as reported
previously (35). Between 15 and 30 randomly chosen fibrils
were measured per sample; widths and lengths are reported as
means  the S.E.
RESULTS
Aggregation Kinetics Reveal Differences in the Lag Phases of
PrPa and PrPb—We compared the aggregation process of
recombinant PrPa (89–230) and PrPb (89–230) in phosphate
buffer, 2 M GdnHCl, pH 7.0 under shaking conditions as
described previously (36). The presence of chaotropic agent
GdnHCl at this concentration has been demonstrated to
improve aggregation efficiency (36). Sigmoidal kinetic profiles
typical for amyloid fibril formation were obtained for both PrPa
and PrPb when the process was followed by measuring changes
in ThT fluorescence intensity (Fig. 1A). A clear difference in lag
phase was observed, with PrPb taking much longer to develop
ThT signal than PrPa. Even with variability between prepara-
tions, PrPb always had longer lag phase (supplemental Fig. S1).
Quantitative analysis of the lag phases was performed as
described previously (34) (see “Experimental Procedures” and
supplemental Fig. S2). Lag phaseswere 36 ( 4.3) h for PrPa and
140 ( 23.0) h for PrPb (Fig. 1C). Of note, these lag phase dif-
ferences were not specific to the denaturing GdnHCl condi-
tions as PrPa also aggregated more quickly than PrPb in acetate
buffer, pH 4.0, under the same temperature and shaking condi-
tions (supplemental Fig. S3).
PrPa and PrPb Lag Phases Differ in Response to Seeding—In
nucleated polymerization, the rate-limiting step is nucleus for-
mation. Therefore, the addition of preformed nuclei should
eliminate the lag phase andpush the process into the elongation
phase. To test whether lag phase could be eliminated in our
reactions, we added preformed fibrils of homologous PrP (PrPa
seeds to PrPamonomers; PrPb seeds to PrPbmonomers).When
the reaction was seeded with 0.5% (v/v) of homologous fibrils
(Fig. 1B), the variability between replicates was lower than in
unseeded reaction. As expected, the lag phase was eliminated
for PrPa; however, although the lag phase for PrPb was substan-
tially reduced from 140 to 20 h, it was not eliminated (Fig. 1C).
Using separate preparations and different concentrations of
seed, these differences were still observed. As little as 0.01%
(v/v) of seed was sufficient to eliminate the lag phase for PrPa
(Fig. 1D). For PrPb, increasing seed from 0.01 to 0.1% (v/v) did
shorten the lag phase from 23.0 ( 0.8) to 17.3 ( 1.1) h, but
further increase of seed concentration to 0.5 and 2% (v/v) had
no effect.
FIGURE 1. Time courses of PrPa and PrPb fibril formation monitored by
ThT fluorescence. PrP (22 M) was incubated in 50 mM phosphate buffer, pH
7.0, 2 M GdnHCl at 37 °C and 500 rpm in the absence or in the presence of
seeds. A and B, kinetics of unseeded (A) and seeded (B) polymerization reac-
tions of PrPa (empty circles) and PrPb (filled circles). C, lag phases for the kinetics
of PrPa (empty bars) and PrPb (filled bars) plotted in A and B. D, lag phase of PrPa
(left) and PrPb (right) aggregation process in the presence of 0.01, 0.1, 0.5, or
2% preformed homologous fibrils. The fibril formation process was followed
by ThT fluorescence, and the lag phase was estimated as the intersection of
quadratic and exponential fitting curves as described under ”Experimental
Procedures.“ Three replicates were plotted for each reaction. Error bars indi-
cate  S.E.
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Cross-seeding Experiments Reveal Similar Efficiency of Seed-
ing by PrPa and PrPb Fibrils—To test whether PrPb fibrils are
simply less efficient at seeding than PrPa fibrils, we added pre-
formed fibrils of heterologous PrP to our reactions (PrPb seeds
were added to PrPa monomers; PrPa seeds were added to PrPb
monomers) (Fig. 2). The lag phase was eliminated when PrPa
was seeded with PrPb fibrils, indicating that PrPb fibrils can
indeed seed efficiently. Surprisingly, an identical residual lag
phase was observed for PrPb regardless of whether reactions
were seededwith heterologous PrPa or homologous PrPb fibrils.
Indications for a Receptive Substrate in the PrPb Aggregation
Mechanism—The residual lag phase in seeded PrPb reactions
indicated that the starting PrPb monomers were not the imme-
diate substrate being incorporated into fibrils during the elon-
gation phase. Rather, a secondary conformation must have
formed first, and it was only this receptive substrate that could
be polymerized by the seeds. The generation of this receptive
substrate could be (i) a “seed-independent” process, where a set
amount of time is required for the starting monomers to form
this substrate; or (ii) a “seed-influenced” process, where the
fibrils actually facilitate receptive substrate formation. To dis-
tinguish between these possibilities, we used a delayed seeding
reaction in which PrPb was put under aggregation conditions
and preformed PrPb fibrils were added at different times during
the lag phase.We predicted that in a seed-independent process,
a set amount of time would be required to form the receptive
substrate followed by the same onset of exponential growth
phase regardless of when the seeds were added. For a seed-
influenced process, we predicted that the onset of exponential
growth would correlate with the timing of seed addition. As
shown in Fig. 3A, the latter phenomenon was demonstrated.
Later seed addition produced longer lag phases (seed time 0, lag
phase 9.4 0.3 h; seed time 5h, lag phase 12.2 0.5 h; seed time
10 h, lag phase 16.2  0.5 h). Also of note was that the later the
seed addition, the less time required between seed addition and
onset of exponential phase (time 0, lag phase 9.4 h; time 5 h, lag
phase 7.2 h; time 10 h, lag phase 6.2 h).
PrPb Seeding Induces an Initial Linear Increase in ThT
Fluorescence—Looking at the ThT fluorescence levels immedi-
ately after seed addition in the delayed seeding experiment, we
observed a small but steady linear increase over time prior to
the exponential growth phase (Fig. 3B). The immediate jump in
ThT can be attributed to the addition of seed as the seed mix-
ture contained some ThT. However, the subsequent rate of
increase of ThT was higher when seed was added later. The
increase (inThTa.u./hour)was 6.8 0.6, 14.4 1.7, and 20.7
2.7, for seeding times of 0, 5, and 10 h, respectively.
ThT-negative Oligomers Are Formed Prior to the Exponential
Growth of PrPb Fibrils—To determine whether oligomeric spe-
cies that do not bind ThT (ThT-negative oligomers) might be
contributing to the early fibrillization process, we examined
seeded and unseeded reactionswith the anionic oligothiophene
derivative p-FTAA,which has been reported to bind prefibrillar
oligomers of recombinant PrP (37). In the absence of seeds, an
increase in p-FTAA signal was observed 20 h before the
increase in ThT signal, demonstrating the early formation of
ThT-negative oligomeric species (Fig. 4). When the reaction
was carried out in the presence of seeds, p-FTAA-positive olig-
omers appeared immediately, whereas ThT-positive fibril for-
mation began 6 h later (Fig. 4).
PrPb Aggregation Is Not Predictably Influenced by Protein
Concentration—In unseeded reactions undergoing nucleation
polymerization, a higher monomer concentration should pro-
duce a shorter lag phase, a higher slope at elongation phase, and
a higher plateau (19). Therefore, we followed the kinetics of
unseeded aggregation as a function of concentration of PrP
FIGURE 2. Time courses of PrPa and PrPb fibril formation in the presence
of homologous and heterologous seeds. Monomeric PrP (22 M) was
seeded with 0.5% (v/v) of fibrils, and the kinetics were followed by ThT fluo-
rescence. A, monomeric PrPa (empty circles) and PrPb (filled circles) were aggre-
gated in the presence of preformed fibrils of homologous PrP (PrPa with PrPa
fibrils; PrPb with PrPb fibrils). B, monomeric PrPa (empty circles) and PrPb (filled
circles) were aggregated in the presence of preformed fibrils of heterologous
PrP (PrPa with PrPb fibrils; PrPb with PrPa fibrils). C, the lag phases for PrPa and
PrPb in the presence of homologous (Homo.) and heterologous (Hete.) seeds
were calculated as described under ”Experimental Procedures.“ The average
of three replicates was plotted for each reaction. Error bars indicate  S.E.
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monomer (Fig. 5). PrPa kinetics were proportional tomonomer
concentration (Fig. 5, A and C). For 11, 16, and 27 M PrPa,
respectively, the lag phases were 36.7 ( 4.3), 26.3 ( 1.2), and
18.0 ( 1.7) h, the slopes for elongation phase were 6.1 ( 0.8),
88.8 ( 7.9), and 191.0 ( 45.2) ThT a.u./h, and the plateaus
were 1180 ( 32), 2790 ( 99), and 4800 ( 111) ThT a.u.
Importantly, these kinetic parameters changed linearly with
monomer concentration, whereas an exponential correlation is
expected from a pure nucleated polymerization model. For
PrPb, no clear correlation was observed between these param-
eters and protein concentration for PrPb (Fig. 5, B and C). In
fact, the highest concentration (27 M) PrPb reactions consis-
tently had the longest lag phases, opposite to what the nucle-
ated polymerization model predicts. There was also signifi-
cantly more kinetic variability among PrPb replicates as shown
in the non-averaged replicate curves in Fig. 5B.
Monomeric PrPa and PrPb Have Similar Secondary Structure—
Given the apparent aggregation differences between starting
monomers for PrPa and PrPb, we compared their secondary
structure by far-ultraviolet circular dichroism (supplemental
Fig. S4). Identical, predominantly-helical signals withminima
at 208 and 222 nm were obtained for both PrPa and PrPb in
Tris-HCl, pH 7.0 (supplemental Fig. S4A). The spectra were
also similar under the conditions used for aggregation experi-
ments (2 M GdnHCl and 37 °C) (supplemental Fig. S4B).
Monomeric PrPa andPrPb ShareDenaturation/Renaturation
Characteristics—A correlation between the thermal lability of
mouse PrP and conversion efficiency has been reported (38),
and distinct unfolding properties of PrPa and PrPb monomers
might explain their different kinetic profiles. We therefore
compared the denaturation profiles of PrPa and PrPb by follow-
ing the 222 nm intensity as a function of temperature or Gdn-
HCl concentration. Loss of the 222 nm minimum correlates
with loss of -helix structure. Thermal denaturation and rena-
turation of PrP produced identical curves for both PrP isoforms
(supplemental Fig. S4C, inset); GdnHCl denaturation curves for
PrPa and PrPb were also identical (supplemental Fig. S4D).
Seed Type Influences the Conformational Stability of PrPb
Fibrils More than PrPa Fibrils—We used a conformational sta-
bility assay to study differences between PrPa and PrPb fibrils
generated under unseeded and seeded conditions. In this assay,
increasing concentrations of GdnHCl are used to gradually
denature the fibrils, rendering themmore susceptible to prote-
olysis with proteinase K. Structural differences in fibrils can
affect the denaturation process and generate distinct protein-
ase K digestion profiles.
All proteinaseK-treated PrPa fibrils yielded prominent bands
of 13 and 18 kDa (Fig. 6, A–C). In unseeded reactions, the
18-kDa band was more intense and more sensitive to protease
action, disappearing in the range of 5.4–5.8 M GdnHCl. The
13-kDa band was still visible at 6 M GdnHCl (Fig. 6A). Similar
results were obtained for PrPa fibrils generated in the presence
of either homologous or heterologous seeds (Fig. 6, B and C).
The pattern was not exactly replicated; the relative band inten-
sities were reversed in the homologous seeded reaction, the
13-kDa band being more intense than the 18-kDa band, and in
FIGURE 3. Kinetics of PrPb aggregation seeded at different times. A, mono-
meric PrPb (22 M) was aggregated in the absence (filled circles) or in the
presence (empty squares, triangles, and circles) of 0.5% (v/v) homologous
seeds. The seeds were added at the beginning of the reaction (squares), after
5 h (triangles), or after 10 h (empty circles). The kinetics were normalized, and
the percentage of ThT fluorescence was graphed. B, the same data were plot-
ted as absolute fluorescence using a different y scale to focus on the pro-
cesses happening before the exponential phase. The slopes were calculated
by fitting the data with linear regression. The arrows in A and the dotted lines
in B indicate the times at which the seeds were added. Three replicates were
averaged for each reaction. Error bars indicate  S.E.
FIGURE 4. PrPb prefibrillar (ThT-negative) oligomer formation monitored
by p-FTAA. Monomeric PrPb (20 M) was put into aggregation assays in
1.5-ml test tubes. 50 l was withdrawn at different times and incubated with
p-FTAA (squares) or ThT (circles) to monitor the formation of prefibrillar olig-
omers and fibril formation, respectively. The assay was carried out in the
absence (filled symbols) or in the presence (empty symbols) of 1% (v/v) of
seeds.
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the heterologous seeded reaction, the intensities of the two
bands were comparable. Also, two other faint bands were only
seen in the unseeded reactions.
In contrast, differences in PrPb fibril stability were more
apparent and highly dependent on the seeding conditions.
Unseeded PrPb fibrils had a pattern similar to unseeded PrPa
fibrils, with a resistant 13-kDa band and amore intense 18-kDa
band that disappeared after 5.4–5.8 M GdnHCl treatment (Fig.
6D). However, under homologous seeding conditions (Fig. 6E),
the 13-kDa band remained resistant and the 18-kDa band was
not present at all, indicating a dramatically different structural
state in these PrPb fibrils. Under heterologous seeding condi-
tions (Fig. 6F), the 18-kDa band was present, was more intense,
and disappeared with 5.8 M GdnHCl, as in the unseeded reac-
tions. The usually resistant 13-kDa band was more sensitive,
disappearing by 5.4 M GdnHCl.
Seed Type Influences the Kinetics of Fibril Formation for PrPb
but Not for PrPa—Based on our conformational stability assay
results, we speculated that if different seeds could strongly
influence the stability of PrPb fibrils generated, different seeds
might also affect PrPb aggregation kinetics more strongly than
PrPa kinetics. Because of the variability of unseeded PrPb fibril
reactions, we were able to generate two PrPb seeds with distinct
kinetic profiles. The “slow” (S) fibrils had an elongation phase
slope of 4.1 ThT a.u./h, whereas the “fast” (F) fibrils had one of
13.6 ThT a.u./h (Fig. 7, dashed and dotted curves). The lag
phases for S and F fibril formation were 15 and 19 h, respec-
tively. S and F seeds were used to seed PrPa and PrPb reactions.
As expected, PrPa lag phase was eliminated regardless of the
type of seed used (Fig. 7A), whereas for PrPb, residual lag phases
between 7 and 9 h occurred with seeding (Fig. 7B). For PrPa, the
kinetics of reactions seeded with S or F were almost identical,
with slopes of 12.5 and 13.5 ThT a.u./h, respectively (Fig. 7A).
These slopes were also similar to those obtained for the elon-
gation phase of unseeded reactions of PrPa (Fig. 7A, open trian-
gles). In contrast, two distinct kinetic profiles were obtained for
PrPb seeded with S or F fibrils, the slopes being 4.1 and 8.7 ThT
a.u./h, respectively (Fig. 7B). The slope of the S-seeded reaction
is identical to that of the original S fibril formation,whereas that
for the F-seeded reaction is intermediate between the original S
and F fibril formation kinetics.
TEM of PrP Fibrils—Fibril production was confirmed using
TEM, and differences between PrPa and PrPb samples were also
noted. All PrPa samples contained straight fibrils of similar
length (600–800 nm) and width (10 and 20 nm in narrow
and wide regions) regardless of whether the fibrils were pro-
duced under seeded or unseeded conditions and regardless of
whether S or F seeds were used (Fig. 8, A–C, and Table 1).
However, although unseeded PrPb fibrils (Fig. 8D) had grossly
similar structures to PrPa fibrils (Table 1), different features
occurred with seeding. PrPb fibrils formed in the presence of F
seeds (Fig. 8E and Table 1) were shorter (100 nm) and uni-
form in width (15 nm); those seeded with S seeds (Fig. 8F and
Table 1)were of intermediate length (300 nm) and sometimes
curved, in contrast to the straight fibrils of PrPa.
FIGURE 5. PrP aggregation at different monomeric concentrations. A and
B, PrPa (A) and PrPb (B) were put into aggregation assays at three different
concentrations: 27 M (squares), 16 M (circles), and 11 M (triangles). Three
replicates were averaged for PrPa (A), but individual replicates were plotted
for PrPb (B) to better display the high heterogeneity observed for these reac-
tions. C, the lag phases for PrPa (empty bars) and PrPb (filled bars) under the
different PrP monomer concentrations were calculated from the intersection
of quadratic and exponential fitting curves, as described under ”Experimental
Procedures.“ Error bars indicate  S.E.
FIGURE 6. Conformational stability assays of PrP fibrils formed under
seeded and unseeded conditions. A–F, Western blot of PrPa (A–C) and PrPb
(D–F) fibrils formed in the absence (A and D) or in the presence of homologous
(B and E) or heterologous (C and F) seeds and subjected to GdnHCl-induced
denaturation and proteinase K digestion. 12 l of proteinase K-treated sam-
ples was analyzed by Western blotting using SAF83 antibody, as described
under “Experimental Procedures.” MW, molecular weight markers.
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In mice, the polymorphisms at positions 108 and 189 are
major determinants of prion disease incubation time (20, 21),
but the molecular basis for this phenomenon is unclear. We
hypothesized that the effect of host PrP sequence on incubation
time was related to themechanism of prion conversion, involv-
ing the oligomerization of PrPC into PrPSc. In this study, we
provide evidence that PrP aggregation does not follow the
canonical nucleation polymerization and that in vivo findings
can be explained by different polymerization kinetics and seed-
ing responses of the two mouse PrP isoforms.
PrPa and PrPb differ only at residues 108 and 189, and we did
not detect differences in -helical content or thermal/chemical
stability between the two monomers. Instead, the primary
differences were found between their kinetic and seeding
behaviors.
Based on our kinetic data, neither PrP isoform follows true
nucleation polymerization. This model predicts that fibril mass
is proportional to t2 during nucleation, meaning that there is
never a flat lag phase (39, 40). BothPrPa andPrPb hadprolonged
flat lag phases in unseeded conditions. This better fits a double-
nucleationmechanism (39). Also, PrPa concentration had a lin-
ear effect on elongation rate and lag phase, as opposed to the
exponential effect predicted by nucleation polymerization.
PrPb concentration did not correlate at all with lag phase, rate of
elongation, or maximum ThT fluorescence. In fact, at highest
PrPb concentration, a paradoxical increase in lag phase was
observed. This is possibly explained by an accumulation of off-
pathway oligomers that interferedwith the aggregation process
(41), although we were not able to detect these by TEM or in
supernatants of centrifuged samples after aggregation.
Other aspects of PrPb kinetics also support an alternate
model. Our data indicate that the PrPb starting monomers, in 2
M GdnHCl, cannot be directly incorporated into fibrils. This is
why the lag phase persists despite the addition of seed. There-
fore, it is a different component, which we call a receptive sub-
strate, that is incorporated into the fibrils during exponential
growth. How then do the starting monomers become receptive
substrates?When unseeded, the startingmonomers do eventu-
ally form receptive substrates and become fibrils, but the proc-
ess is extremely longwith greater variation in kinetic profile and
fibril structure. This variability suggests that a number of path-
ways to receptive substrate formation are possible and that sev-
eral different receptive substrates can be produced, each of
which then produces a different kinetic profile and fibril prod-
uct. Alvarez-Martinez et al. (42) have explained variation in
aggregation kinetics by proposing the existence of “conforma-
tionally active monomers,” which randomly form different
nuclei. Whichever nucleus forms first is the one that dictates
the dynamics of the aggregation process and the resulting fibril
structure. This model could explain the variability seen in our
data, but not why we cannot eliminate the lag phase with seed-
ing nor why we do not see a correlation between PrPb kinetics
and monomer concentration. Rather than monomers, our data
suggest that conformationally active oligomersmay be the nec-
essary precursors to the formation of receptive substrates.
If the production of conformationally active oligomers is the
rate-limiting step, dependent on structural change from the
monomer state, it follows that changes inmonomer concentra-
tion will not facilitate the process of fibril growth, as found in
our study. Also, the addition of seed to startingmonomers does
not immediately lead to exponential growth in PrPb because
starting monomers must first form conformationally active
oligomers and then receptive substrates; only the receptive sub-
strates are incorporated into fibril growth. The presence of
these early oligomers (ThT-negative and ThT-low oligomers)
was confirmed by p-FTAA fluorescence. A similar mechanism,
“nucleated conformational conversion,” has been described for
the yeast prion element [PSI] where nuclei are formed by
conformational rearrangement of less structured oligomeric
intermediates that are in equilibrium with monomers (43).
Of note, although seeding does not eliminate PrPb lag phase,
seed addition does greatly accelerate the time to exponential
growth phase, meaning that the seed must be affecting the
process in somemanner. Seed addition produces an immediate
and rapid increase in p-FTAA fluorescence and a slower linear
increase in ThT fluorescence (prior to the exponential growth
phase), with later addition yielding both a higher rate of ThT
increase and a shorter time to onset of exponential growth
phase. Given this, we propose the followingmechanism (Fig. 9).
Starting monomers gradually aggregate into larger and larger
oligomers (which are ThT-negative but p-FTAA-positive).
When these ThT-negative oligomers bind seeds, they become
conformationally active and acquire some low ThT fluores-
cence (ThT-low, p-FTAA-positive), but do not yet become fully
receptive substrates (and therefore do not undergo exponential
growth). As larger ThT-negative oligomers are expected to
accumulate over time, seeds that are added to the process later
will bind larger ThT-negative oligomers that in turn become
conformationally active, thus producing higher rates of ThT
increase. The larger oligomers may also be closer to adopting a
FIGURE 7. Influence of slow and fast seeds on the kinetics of PrP fibril
formation. A and B, 22 M PrPa (A) or PrPb (B) was incubated in the absence (A,
open triangles) or the presence of 0.5% (v/v) slow (filled circles) or fast (filled
squares) seeds. The original kinetics of the reactions that produced the S and
F seeds are shown for comparison, as a dotted line (F) and dashed line (S). n 	
3 for unseeded reactions; n 	 2 for seeded reactions. Error bars indicate  S.E.
FIGURE 8. Influence of different seeds on the structure of PrP fibrils. a–f,
images of PrPa (a– c) and PrPb (d–f) fibrils generated in the absence of seeds (a
and d) or in the presence of fast (b and e) or slow (c and f) seeds were obtained
by TEM. Scale bars, 100 nm.
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receptive substrate conformation, which would explain why
there is an apparent acceleration to exponential phase after
delayed seed addition.
It should be noted that PrPa could fundamentally share the
mechanism thatwe propose for PrPb and still display the kinetic
and seeding tendencies we observed. If PrPa converts to confor-
mationally active oligomers and then to receptive substrates
more efficiently, and is not rate-limiting, the conformationally
active oligomers would not be detectable in our seeded kinetic
studies. The efficient formation of receptive substrates might
correlate with less off-pathway aggregation, explaining the
shorter lag phases and reduced variability seen in unseeded
PrPa reactions. It would also explain why PrPa is not overly
influenced by seed type; there is less time for seed and oligomer
to interact.
We are proposing that the seed induces structural change
without immediately triggering polymerization. Such a process
has been described in “surface-catalyzed nucleation,” where
monomers nonspecifically bind the lateral aspects of fibrils
with subsequent conformational rearrangement to form on
pathway oligomers, and ultimately nuclei, which can bind the
ends of fibrils and proceed with exponential growth (44, 45).
Such lateral association is a recognized process in recombinant
PrP fibril formation (46).
Somewhat unexpectedly, our conformational stability assay
and TEM experiments revealed that PrPb may be structurally
influenced by seeds to a greater extent than PrPa; the morphol-
ogy and stability of PrPa fibrils did not vary as much as PrPb
fibrils. Also, PrPb more closely mimicked the kinetics of the
seeds used.
The purpose of this study was to gain insight into how poly-
morphisms of PrP translate into phenotypic differences in
prion disease by studying kinetic profiles of fibril formation in
vitro. The long lag phases for PrPb correlate with long incuba-
tion times in Prnpbmice (21–25). In addition, if conformation-
ally active oligomers are part of the PrP aggregation mecha-
nisms, they may present a new therapeutic target, one that lies
structurally in between monomeric and fibrillar states. Finally,
our data may also inform the study where a shorter incubation
timewas seen inPrnpbmice.Here, strain propertiesmay be key,
and we have found that PrPb appears to be more strongly influ-
enced by the type of seed used. Importantly, this seed influ-
ence could have risk implications as hosts presumed to be
less susceptible based on PrP sequence may simply need to
be exposed to the appropriate strain. A real life example of
this can be found in the rise of chronic wasting disease. At
present, chronic wasting disease does not appear to cross the
species barriers into humans, but there is growing evidence
for distinct strains of chronic wasting disease, and the influ-
ence of human PrP polymorphism on their transmission
characteristics is unknown.
TABLE 1
Quantitative analysis of PrPa and PrPb fibrils generated under unseeded and seeded conditions
The width and length (expressed in nm  S.E.) of fibrils from the six samples depicted in Fig. 8 were determined.
PrPa fibrils PrPb fibrils
Unseeded Fast seeds Slow seeds Unseeded Fast seeds Slow seeds
No. of fibrils analyzed 21 27 23 15 18 20
Fibril width narrow region 10.7  0.8 9.6  0.6 8.8  0.6 10.2  0.6 14.5  0.7 (uniform width) 8.4  0.4
Fibril width wide region 23.3  0.8 20.7  1.1 19.5  1.1 19.2  1.1 14.5  0.7 (uniform width) 20.0  1.1
Fibril length 821  126 681  82 602  67 616  86 102  13 332  58
FIGURE 9. Proposed mechanism of PrPb fibril formation in unseeded and delayed seeding conditions. A, the unseeded reaction is shown, where
monomers (dark triangles) first form ThT-negative (p-FTAA-positive) oligomers of increasing size and ultimately form conformationally active oligomers (light
triangles, ThT-low, p-FTAA-positive) followed many hours later by receptive substrates (white squares, ThT-high), which go on to form fibrils. B, a typical seeded
reaction is shown, with seed added at time 0. When monomers bind seed, they are immediately converted into a conformationally active state (ThT-low,
p-FTAA-positive). As more monomers bind and are converted, a sufficient number or size is reached such that receptive substrates form. C and D, with delayed
seeding, larger ThT-negative (p-FTAA-positive) oligomers are already present when seed is added, so immediate conversion of the larger oligomers occurs
(becoming ThT-low, p-FTAA-positive), giving a greater linear increase in ThT fluorescence signal over time and allowing receptive substrates to form in a
shorter time period after seed addition.
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